Search

everythinglearnresearchcommunity

for

Search:↓

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

Intravenous calcium therapy is a safe and effective treatment for a rare type of rickets.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Longdan Xiegan decoction is more effective than conventional medicine for treating eczema.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

High-dose IV iron is safe and effective for treating anaemia in IBD patients.

Mogamulizumab can cause hair loss and skin rashes.

Rituximab may cause skin issues, but baricitinib can help improve them.

Upadacitinib improved multiple immune-related conditions in one patient.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

Cedrol may help reduce liver fat and fat cell growth caused by corticosteroids.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Thalidomide improved lupus symptoms but caused nerve damage in some patients.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Individualized treatments may help manage Dercum's disease symptoms.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Wedelolactone may help treat lung fibrosis by reducing inflammation and lung damage.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.